Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg-Reference-Cited by-同舟云学术

Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg

Published:2018-09 Issue: Volume:62 Page:59-66
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Nianqiu,Liu Bin,Zhang Li,Li Hu,Chen Zhiwei,Luo Aoran,Chen Min,Peng Mingli,Yin Wenwei,Ren Hong,Hu Peng^ORCID

Funder

National Natural Science Foundation of China

National Science and Technology Major Project of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference28 articles.

1. Hepatitis B;WHO,2017

2. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B;Li;World J. Gastroenterol.,2014

3. A better antiviral efficacy found in nucleos(t)ide analog (NA) combinations with interferon therapy than NA monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis;Wei;Int. J. Environ. Res. Public Health,2015

4. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection;Zerbini;Gastroenterology,2008

5. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen;Jegaskanda;J. Virol.,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma;Immunology;2023-12-14

2. Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue;Liver Research;2023-06

3. A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults;Antiviral Therapy;2023-05-18

4. Recovery of host adaptive immune function promoted the reduction of hepatitis B surface antigen in nucleoside analog-experienced chronic hepatitis B patients with low hepatitis B surface antigen levels;Cytokine;2023-04

5. Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases;Journal of Clinical and Translational Hepatology;2023-01-16